Key result
This review summarizes past and present stent technologies, emphasizing the principles underlying the efficacy and safety of drug-eluting stents for treating symptomatic coronary artery disease.
This review provides a comprehensive overview of the evolution of intracoronary stent technologies, emphasizing advancements aimed at optimizing both clinical efficacy and safety in treating coronary artery disease.
The introduction of intracoronary stents represented a major advance in interventional cardiology. While bare metal stents set the benchmark for improved safety over angioplasty, intimal hyperplasia and subsequent restenosis were important limitations. First-generation drug-eluting stents demonstrated significant improvements in efficacy, but not necessarily safety, and further technologic developments have focused on optimizing both. Current advances and understanding in stent design continue to improve on these concepts. This review summarizes past and present technology with particular emphasis on the principles underlying the efficacy and safety of drug-eluting stents, and offers a glimpse into the next generations of stents aimed at treating symptomatic coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Steinberg et al. (2014) conducted a review in symptomatic coronary artery disease. Stent technologies was evaluated. This review summarizes past and present stent technologies, emphasizing the principles underlying the efficacy and safety of drug-eluting stents for treating symptomatic coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: